« back to directory
Company Profile
Molecule2Market
- info@molecule2.com.au
- https://molecule2.com.au/
- https://www.facebook.com/Molecule2Market/
- https://www.linkedin.com/company/molecule2market/
- Ground floor, 35 Cotham Road, Kew, VIC, 3101, Australia
About Molecule2Market
Molecule2Market (M2M) is a boutique CRO dedicated to advancing Australia’s contribution to the research and development of innovative medical treatments. Combining the strength of our expertise and experience, we provide high quality services across all phases of clinical research and a broad range of therapeutic areas. M2M services cover all aspects of clinical research including:
- Project Feasibility
- Site Selection
- Study Start-Up
- Project Management
- Monitoring
- Local Safety Reporting
- Site Close Out
Our Directors Anne De Luca and Robin Hansen are able to leverage over 50 years collective experience in all facets of clinical trials to ensure M2M consistently delivers successful client outcomes. Our leadership team members each has a minimum of 15 years’ experience.
M2M offers our clients the simplicity of support through one organisation. We provide services in pharmaceutical and device research development and commercialisation in a highly flexible manner to meet customer needs. These include:
- Clinical
- Regulatory
- Quality Assurance and Auditing
- Data Management/Statistics
- Medical Writing
- Medical Monitoring
- Local Study Sponsorship
- Applying the Australian R&D Tax Incentive when Conducting Research in Australia
M2M is a proud member of AICROS, the Association of International Contract Research Organisations. AICROS is an alliance of local and well established CROs providing clinical research services on a global scale, offering high quality customised solutions through strong local service providers.